An ongoing dialogue on HIV/AIDS, infectious diseases,
March 16th, 2020
Difficult Times — Meaning No CROI Really Rapid Review 2020
In a usual year, right about now, I’d be obsessed with two things:
- What were the most practice-changing studies presented at the Conference on Retroviruses and Opportunistic Infections, or CROI? I’d want to summarize those for a patented, copyright-protected, check-with-my-lawyer-before-copying, Really Rapid Review©®.
- How will the upcoming baseball season play out? Most readers here don’t care, I concede. Oh well, we all have our enthusiasms.
But this isn’t a usual year, especially not for us specialists in Infectious Diseases.
Baseball is on hold for now, thank you coronavirus — they say two weeks, but everyone knows it will be longer. Who knows.
As for CROI? Due to some remarkable sleight of hand, at the last minute it became a virtual meeting, with research and plenaries presented online. The planners moderated the sessions in place right here in Boston — but no one attended live.
I thought about writing a Really Rapid Review©® on this electronic CROI.
But I was so distracted by COVID-19 activities that it was tricky. (Ok. Impossible.) Today I concluded that the product wouldn’t meet the high standards of those who read this site regularly, for which you have my sincere gratitude.
Meanwhile, you can take a look at this isolated citation from the conference. I do think it is the most important practice-changing study from CROI 2020 — how often do we see randomized clinical trials in pregnant women with HIV?
(HARDLY EVER. There, I answered.)
It’s called IMPAACT 2010. And with the disclosure that I’m a (relatively unimportant) co-investigator on the study, and obviously some disappointment that it didn’t get the attention it deserved, here’s a take-home message — DTG + TAF/FTC may well be the best regimen for treatment-naive pregnant women.
Important, practice-changing RCT presented a #CROI2020 on Rx of HIV in pregnancy. Take-homes:
– DTG superior to EFV in viral suppression
– TAF/FTC+DTG best for adverse pregnancy outcomes
– Weight gain most with TAF/FTC+DTG; closest to rec wt changes @IMPAACTNetwork pic.twitter.com/6mNWstFbVX— Paul Sax (@PaulSaxMD) March 11, 2020
Meanwhile, if you want to know how your fellow ID doc feels right now, take it away Adi:
Medical professionals internally right now pic.twitter.com/vYlABMUycv
— Adi (@IDdocAdi) March 16, 2020
Thank you for your patience. And take care of yourself during this difficult time.
Thanks for giving time to the blog Paul! Always a delight to read.
Please do not underestimate the healing powers of opening day. Some of your readers are ardent baseball fans!
Exactly what Matt Kuhlmann says above!
Thanks, as always, for your posts, Paul. Always the perfect combination of informative, insightful and witty.
There were some issues regarding neonates being born with neural tube defects in women exposed to DTG during pregnancy. How has this concern finally been addressed ?
Is there any hope or is this really it?? I guess just looking for some reassurance if there happens to be any….. thanks!